Table Of Contents
1 Introduction 32
1.1 Overview Of Global Advanced Wound Care Market 32
1.2 Currency And Pricing 34
1.3 Limitation 34
1.4 Markets Covered 35
2 Market Segmentation 38
2.1 Markets Covered 38
2.2 Geographic Scope 39
2.3 Years Considered For The Study 40
2.4 Currency And Pricing 40
2.5 Research Methodology 41
2.6 Primary Interviews With Key Opinion Leaders 44
2.7 Secondary Sources 45
2.8 Assumptions 45
3 Market Overview 46
3.1 Drivers 48
3.1.1 Rising Ageing And Geriatric Population 48
3.1.2 Technological Advancement 48
3.1.3 Government Support 49
3.1.4 Rising Incidences Of Chronic Wound 50
3.1.5 Increasing Trend 51
3.2 Restraints 51
3.2.1 Low Awareness 51
3.2.2 Slow Growth Rate And Shrinking Market 52
3.2.3 Complex Regulatory Approval Process 52
3.2.4 Competition With Other Moist Dressings 53
3.3 Opportunities 53
3.3.1 Reimbursement 53
3.3.2 Mergers And Acquisitions To Expand Business 54
3.3.3 Unmet Needs 54
3.3.4 Increasing Demand 55
3.4 Challenges 55
3.4.1 Shortage Of Trained Staff 55
3.4.2 The Development Of Substitute Products 55
?
3.5 Key Market Trends And Upcomming Technologies 56
3.5.1 Smart Dressing Will Push Future Growth 56
3.5.2 Hydrofiber Has Been The Most Significant Recent Innovation 56
3.5.3 Alginate Dressing Is Expected To Grow Robustly In The Upcoming Years 56
3.5.4 Foam Dressing Accounting The Largest Market Segment In The Upcoming Years 56
4 Executive Summary 57
5 Premium Insights 61
6 Global Advanced Wound Care Market, By Product Type 64
6.1 Overview 65
6.2 Dressing 67
6.2.1 Dressing On The Basis Of Product Type 68
6.2.1.1 Film Dressings 68
6.2.1.2 Foam Dressings 69
6.2.1.3 Hydrogels 69
6.2.1.4 Alginates 70
6.2.1.5 Wound Contact Layer 70
6.2.1.6 Super Absorbent Dressing 71
6.3 Biologics 72
6.3.1 Biologics On The Basis Of Product Type 72
6.3.1.1 Allografts 73
6.3.1.2 Synthetic Skin Grafts 73
6.3.1.3 Xenografts 73
6.3.1.4 Growth Factors 74
6.3.1.4.1 Platelet Derived Growth Factor (Pdgf) 74
6.3.1.4.2 Platelet Rich Plasma (Prp) 74
6.3.1.4.3 Epidermal Growth Factors (Egf) 76
6.3.1.4.4 Basic Fibroblast Growth Factors (Bfgf) 76
6.3.1.4.5 Granulocyte Colony Stimulating Factor (G-Csf) 76
6.3.1.4.6 Talactoferrin Alfa 77
6.3.1.4.7 Thrombin Peptide 77
6.3.1.4.8 Keratinocy Growth Factor (Kgf) 77
6.4 Therapy Devices 78
6.4.1 Therapy Devices On The Basis Of Product Type 78
6.4.1.1 Negative Pressure Wound Therapy (Npwt) 79
6.4.1.1.1 Portable Npwt Devices 79
6.4.1.1.2 Disposable Npwt Devices 80
6.4.1.2 Pressure Relief Devices 80
6.4.1.3 Hyperbaric Oxygen Chambers 80
6.4.1.3.1 Monoplace 80
6.4.1.3.2 Multiplace 81
6.4.1.3.3 Topical 81
6.4.1.4 Wound Debridement Devices 82
6.4.1.4.1 Hydrosurgical 82
6.4.1.4.2 Ultrasound 82
6.4.1.4.3 Mechanical 82
6.4.1.4.4 Others 82
6.4.1.5 Physical Therapies 83
6.4.1.5.1 Laser Therapy 83
6.4.1.5.2 Electrical Stimulation 83
6.4.1.5.3 External Shock Wave Therapies 84
6.4.1.5.4 Saline Mist Therapy 84
7 Global Advanced Wound Care Market, By Wound Type 85
7.1 Introduction 86
7.2 Surgical Wound 88
7.2.1 Class I 88
7.2.2 Class Ii 88
7.2.3 Class Iii 88
7.2.4 Class Iv 88
7.3 Diabetic Ulcers 89
7.4 Pressure Ulcers 90
7.5 Venous Ulcers 91
7.6 Burns 91
8 Global Advanced Wound Care Market, By End User 92
8.1 Overview 93
8.2 Hospitals 94
8.3 Wound Care Centers 94
8.4 Ambulatory Centers 94
8.5 Home Healthcare 94
8.6 Clinics 95
8.7 Community Healthcare 95
?
9 Global Advanced Wound Care Market, By Distribution Channel 96
9.1 Overview 97
9.2 Direct Tenders 97
9.3 Retail 97
10 Global Advanced Wound Care Market By Geography 98
10.1 Overview 98
10.2 North America 105
10.2.1 U.S. 118
10.2.2 Canada 125
10.2.3 Mexico 132
10.3 Europe 139
10.3.1 Germany 152
10.3.2 France 159
10.3.3 U.K. 166
10.3.4 Italy 173
10.3.5 Spain 180
10.3.6 Russia 187
10.3.7 Netherlands 194
10.3.8 Switzerland 201
10.3.9 Belgium 208
10.3.10 Turkey 215
10.3.11 Rest Of Europe 222
10.4 Asia-Pacific 223
10.4.1 Japan 236
10.4.2 China 243
10.4.3 South Korea 250
10.4.4 India 257
10.4.5 Australia 264
10.4.6 Thailand 270
10.4.7 Singapore 277
10.4.8 Malaysia 284
10.4.9 Philippines Advanced Wound Care Market 291
10.4.10 Indonesia 298
10.4.11 Rest Of Asia-Pacific 305
10.5 South America 306
10.5.1 Brazil 319
10.5.2 Rest Of South America 326
?
10.6 Middle East And Africa 327
10.6.1 South Africa 340
10.6.2 Saudi Arabia 347
10.6.3 United Arab Emirates 354
10.6.4 Rest Of Middle East And Africa 361
11 Global Advanced Wound Care Market, Company Share 362
11.1 Company Share Analysis; Global 362
11.2 Company Share Analysis; North America 363
11.3 Company Share Analysis; Europe 364
11.4 Company Share Analysis; Asia-Pacific (Apac) 365
12 Company Profile 366
12.1 Acelity L.P. Inc. (Subsidary Of Allargan) 366
12.1.1 Company Overview 366
12.1.2 Company Share Analysis 366
12.1.3 Product Portfolio 367
12.1.4 Recent Developments 369
12.2 Smith And Nephew 370
12.2.1 Company Overview 370
12.2.2 Company Share Analysis 370
12.2.3 Revenue Analysis 371
12.2.4 Product Portfolio 371
12.2.5 Recent Developments 372
12.3 Molnlycke Healthcare 373
12.3.1 Company Overview 373
12.3.2 Company Share Analysis 373
12.3.3 Global Presence 374
12.3.4 Product Portfolio 374
12.3.5 Recent Developments 375
12.4 3M 376
12.4.1 Company Overview 376
12.4.2 Company Share Analysis 376
12.4.3 Revenue Analysis 377
12.4.4 Product Portfolio 377
12.4.5 Recent Developments 379
12.5 Baxter 380
12.5.1 Company Overview 380
12.5.2 Revenue Analysis 380
12.5.3 Product Portfolio 381
12.5.4 Recent Developments 381
12.6 Coloplast 382
12.6.1 Company Overview 382
12.6.2 Revenue Analysis 382
12.6.3 Product Portfolio 383
12.6.4 Recent Developments 383
12.7 Convatec Inc. 384
12.7.1 Company Overview 384
12.7.2 Revenue Analysis 384
12.7.3 Product Portfolio 385
12.7.4 Recent Developments 386
12.8 Derma Sciences Inc (Subsidiary Of Integra Life Sciences) 387
12.8.1 Company Overview 387
12.8.2 Global Presence 387
12.8.3 Product Portfolio 387
12.8.4 Recent Developments 389
12.9 Ethicon Inc (Subsidiary Of Johnson And Johnson Services, Inc ) 390
12.9.1 Company Overview 390
12.9.2 Global Presence 390
12.9.3 Product Portfolio 391
12.9.4 Recent Developments 391
12.10 Integra Life Sciences Corporation 392
12.10.1 Company Overview 392
12.10.2 Revenue Analysis 392
12.10.3 Product Portfolio 393
12.10.4 Recent Developments 394
12.11 Paul Hartmann Limited 395
12.11.1 Company Overview 395
12.11.2 Revenue Analysis 395
12.11.3 Product Portfolio 396
12.11.4 Recent Development 396
12.12 Organogenesis Inc 397
12.12.1 Company Overview 397
12.12.2 Global Presence 397
12.12.3 Product Portfolio 398
12.12.4 Recent Developments 398
13 Related Reports 399
?